Literature DB >> 10395084

Urokinase plasminogen activator induces human smooth muscle cell migration and proliferation via distinct receptor-dependent and proteolysis-dependent mechanisms.

V Stepanova1, S Mukhina, E Köhler, T J Resink, P Erne, V A Tkachuk.   

Abstract

In order to define the relative contribution of the proteolytic domain and the receptor-binding domain of urokinase plasminogen activator (uPA) toward its mitogenic properties we studied the effects of different uPA isoforms on migration and proliferation of human aortic smooth muscle cells (hSMC). The isoforms tested included native human glycosylated uPA, and two recombinant uPA forms, namely a recombinant uPA with wild type structure (r-uPA), and a uPA-mutant in which the first 24 N-terminal amino acid residues of the receptor binding domain were replaced by 13 foreign amino acid residues (r-uPAmut). Cell migration was evaluated using a micro-Boyden chamber assay, and cell proliferation assessed by measurement of [3H]-thymidine incorporation into DNA. Competition binding studies on hSMC using 125I-r-uPA as ligand demonstrated that r-uPA and r-uPAmut exhibited equivalent displacement profiles. However, migration of hSMC was promoted by r-uPA and not by r-uPAmut. r-uPA-induced migration occurred at concentrations (half-maximally effective concentration of 2 nM) approximating the Kd for uPA-uPAR binding (1 nM). r-uPA-induced migration was not affected by the plasmin inhibitor aprotinin. In contrast to their differential chemotactic properties, uPA, r-uPA and r-uPAmut, which possess similar proteolytic activities, all stimulated [3H]-thymidine incorporation in hSMC. Since the [3H]-thymidine incorporation response to each isoform occurred at concentrations (> 50 nM) much higher than necessary for uPAR saturation by ligand (1 nM), this mitogenic response may be independent of binding to uPAR. [3H]-thymidine incorporation responses to r-uPA and -uPAmut were sensitive to the plasmin inhibitor aprotinin, and uPA stimulated DNA synthesis was inhibited by plasminogen activator inhibitor. We conclude that hSMC migration in response to uPA depends upon on its binding to uPAR, whereas uPA-stimulated DNA synthesis in these cells requires proteolysis and plasmin generation.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10395084     DOI: 10.1023/a:1006936623106

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  32 in total

1.  Urokinase plasminogen activator induces smooth muscle cell migration: key role of growth factor-like domain.

Authors:  V Stepanova; A Bobik; R Bibilashvily; A Belogurov; I Rybalkin; S Domogatsky; P J Little; E Goncharova; V Tkachuk
Journal:  FEBS Lett       Date:  1997-09-08       Impact factor: 4.124

2.  Smooth muscle cells express urokinase during mitogenesis and tissue-type plasminogen activator during migration in injured rat carotid artery.

Authors:  A W Clowes; M M Clowes; Y P Au; M A Reidy; D Belin
Journal:  Circ Res       Date:  1990-07       Impact factor: 17.367

3.  An amino-terminal fragment of urokinase isolated from a prostate cancer cell line (PC-3) is mitogenic for osteoblast-like cells.

Authors:  S A Rabbani; J Desjardins; A W Bell; D Banville; A Mazar; J Henkin; D Goltzman
Journal:  Biochem Biophys Res Commun       Date:  1990-12-31       Impact factor: 3.575

4.  The urokinase receptor is required for human monocyte chemotaxis in vitro.

Authors:  M R Gyetko; R F Todd; C C Wilkinson; R G Sitrin
Journal:  J Clin Invest       Date:  1994-04       Impact factor: 14.808

5.  Dynamic expression of alpha 1 beta 1 and alpha 2 beta 1 integrin receptors by human vascular smooth muscle cells. Alpha 2 beta 1 integrin is required for chemotaxis across type I collagen-coated membranes.

Authors:  M P Skinner; E W Raines; R Ross
Journal:  Am J Pathol       Date:  1994-11       Impact factor: 4.307

6.  Production of second messengers following chemotactic and mitogenic urokinase-receptor interaction in human fibroblasts and mouse fibroblasts transfected with human urokinase receptor.

Authors:  E Anichini; G Fibbi; M Pucci; R Caldini; M Chevanne; M Del Rosso
Journal:  Exp Cell Res       Date:  1994-08       Impact factor: 3.905

7.  Structural requirements for the growth factor activity of the amino-terminal domain of urokinase.

Authors:  S A Rabbani; A P Mazar; S M Bernier; M Haq; I Bolivar; J Henkin; D Goltzman
Journal:  J Biol Chem       Date:  1992-07-15       Impact factor: 5.157

8.  The ligand-binding domain of the cell surface receptor for urokinase-type plasminogen activator.

Authors:  N Behrendt; M Ploug; L Patthy; G Houen; F Blasi; K Danø
Journal:  J Biol Chem       Date:  1991-04-25       Impact factor: 5.157

9.  Urokinase-urokinase receptor interaction: non-mitogenic signal transduction in human epidermal cells.

Authors:  M Del Rosso; E Anichini; N Pedersen; F Blasi; G Fibbi; M Pucci; M Ruggiero
Journal:  Biochem Biophys Res Commun       Date:  1993-01-29       Impact factor: 3.575

10.  Proteolytic cleavage of the urokinase receptor substitutes for the agonist-induced chemotactic effect.

Authors:  M Resnati; M Guttinger; S Valcamonica; N Sidenius; F Blasi; F Fazioli
Journal:  EMBO J       Date:  1996-04-01       Impact factor: 11.598

View more
  7 in total

1.  Fibulin-5 binds urokinase-type plasminogen activator and mediates urokinase-stimulated β1-integrin-dependent cell migration.

Authors:  Alexander Kapustin; Victoria Stepanova; Natalia Aniol; Douglas B Cines; Alexei Poliakov; Serge Yarovoi; Tatiana Lebedeva; Robin Wait; Grigory Ryzhakov; Yelena Parfyonova; Yaroslav Gursky; Hiromi Yanagisawa; Mikhail Minashkin; Robert Beabealashvilli; Alexander Vorotnikov; Alex Bobik; Vsevolod Tkachuk
Journal:  Biochem J       Date:  2012-04-15       Impact factor: 3.857

2.  Urokinase-type Plasminogen Activator (uPA) Promotes Angiogenesis by Attenuating Proline-rich Homeodomain Protein (PRH) Transcription Factor Activity and De-repressing Vascular Endothelial Growth Factor (VEGF) Receptor Expression.

Authors:  Victoria Stepanova; Padma-Sheela Jayaraman; Sergei V Zaitsev; Tatiana Lebedeva; Khalil Bdeir; Rachael Kershaw; Kelci R Holman; Yelena V Parfyonova; Ekaterina V Semina; Irina B Beloglazova; Vsevolod A Tkachuk; Douglas B Cines
Journal:  J Biol Chem       Date:  2016-05-04       Impact factor: 5.157

3.  Urokinase-type plasminogen activator is a preferred substrate of the human epithelium serine protease tryptase epsilon/PRSS22.

Authors:  Shinsuke Yasuda; Nasa Morokawa; G William Wong; Andrea Rossi; Mallur S Madhusudhan; Andrej Sali; Yuko S Askew; Roberto Adachi; Gary A Silverman; Steven A Krilis; Richard L Stevens
Journal:  Blood       Date:  2005-02-08       Impact factor: 22.113

4.  Mechanisms of kringle fragment of urokinase-induced vascular smooth muscle cell migration.

Authors:  Elisa Roztocil; Suzanne M Nicholl; Mark G Davies
Journal:  J Surg Res       Date:  2007-07       Impact factor: 2.192

5.  Protease-mediated human smooth muscle cell proliferation by urokinase requires epidermal growth factor receptor transactivation by triple membrane signaling.

Authors:  Enrico A Duru; Yuyang Fu; Mark G Davies
Journal:  J Surg Res       Date:  2014-07-02       Impact factor: 2.192

6.  Cell migration in response to the amino-terminal fragment of urokinase requires epidermal growth factor receptor activation through an ADAM-mediated mechanism.

Authors:  Andrew M Bakken; Clinton D Protack; Elisa Roztocil; Suzanne M Nicholl; Mark G Davies
Journal:  J Vasc Surg       Date:  2009-05       Impact factor: 4.268

7.  The study of t-PA, u-PA and PAI-1 genes polymorphisms in patients with abdominal aortic aneurysm.

Authors:  Katarzyna Oszajca; Konrad Wroński; Grażyna Janiszewska; Małgorzata Bieńkiewicz; Jacek Bartkowiak; Janusz Szemraj
Journal:  Mol Biol Rep       Date:  2014-01-23       Impact factor: 2.316

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.